Data / Form D filings / BioLattice Ophthalmics, Inc,
BioLattice Ophthalmics, Inc,: Form D filings
BioLattice Ophthalmics, Inc,, a biotechnology company in Philadelphia, PA, filed 2 Form D notices with the SEC in 2026. The latest, on October 28, 2026, reports $1.8 million sold of a $3.3 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2929 Arch Street, Philadelphia, PA, 19104
- Phone
- (267) 481-5423
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2125596
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 28, 2026 | Amendment | $3,310,000 | $1,825,000 | $1,485,000 | 7 | Mar 6, 2026 | sec.gov |
| Mar 30, 2026 | New notice | $2,500,000 | $575,000 | $1,925,000 | 2 | Mar 6, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Linda Alunkal | Executive Officer, Director | |
| Amelia Zellander | Executive Officer, Director | |
| Gregory Jackson | Director |
Other biotechnology companies in Pennsylvania that filed recently
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
- Aposture Surgical Corp $87,000 · Aug 13, 2026
Every Form D from the week of Oct 26, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioLattice Ophthalmics, Inc, reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.